Answers are grounded in this paper and cite their sources.
In Brief Objective: To evaluate the expression of carbonic anhydrase IX (CA IX) and vascular-endothelial growth factor (VEGF) in esophageal and gastric adenocarcinomas and in turn with the histologic subtype. Summary Background Data: Tumor hypoxia is an important factor in therapy resistance. A low oxygen concentration in tumors stimulates a.o. the expression of CA IX, a marker of hypoxia, and VEGF, a pro-angiogenic factor. Methods: We evaluated the immunohistochemical expression of CA IX and VEGF on paraffin-embedded material of 154 resection specimens: 39 esophageal, 73 cardiac, and 42 distal gastric adenocarcinomas (UICC classification). The adenocarcinomas were subtyped according to the Lauren classification (intestinal- and diffuse-type). Statistical Analysis: χ2 test, Kaplan-Meier survival analysis, log-rank test, and Cox proportional hazards model. Results: CA IX and VEGF expression were independent of the localization of the tumor. However, intestinal-type adenocarcinomas showed a significantly higher expression of CA IX as well as VEGF than diffuse-type tumors. VEGF expression was associated with a high microvessel density. Although survival analysis showed that CA IX expression (P = 0.008) as well as the coexpression of CA IX and VEGF (P = 0.008) correlate with a poor outcome, only CA IX expression is an independent prognostic factor for overall survival and metastasis-free survival. Conclusion: The difference in expression of CA IX and VEGF between intestinal- and diffuse-type adenocarcinomas may possibly explain the different clinical behavior of these tumors. CA IX expression, rather than VEGF positivity in tumors, enables the identification of a subpopulation, characterized by a more aggressive behavior and a poorer prognosis. Intestinal- and diffuse-type adenocarcinomas differ by histogenesis, clinical behavior, metastasis pattern, and prognosis. The intestinal-type adenocarcinomas express more frequently a hypoxia-related protein CA IX and a pro-angiogenic factor VEGF than diffuse-type adenocarcinomas. CA IX expression, rather than VEGF, correlates with poor survival.
No takes yet. Share an insight, caveat, or question.
Driessen et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: